Search research articles
Contact Us
Filters
Showing results (11-20 of 180) with videos related to
Page
of 18
Sort By:
Pediatric Hematology and Oncology
|
November 10, 2017
Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting
Alan S Wayne, Erika Shin-Kashiyama, Richard Sposto, et al.
Cancer
|
February 14, 2015
Improving access to novel agents for childhood leukemia
Weili Sun, Paul S Gaynon, Richard Sposto, et al.
Cancer Research
|
September 30, 2010
Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia
Tanja Andrea Gruber, Mi Sook Chang, Richard Sposto, et al.
Carcinogenesis
|
October 27, 2025
Recent evolution of risk analyses in atomic bomb survivor studies: new methods and applications
John Cologne, Munechika Misumi, Hanna Lindner, et al.
Leukemia
|
March 19, 2018
Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis
Maria Maruffi, Richard Sposto, Matthew J Oberley, et al.
Pediatric Blood & Cancer
|
January 22, 2013
A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors
Leo Mascarenhas, Marcio Malogolowkin, Saro H Armenian, et al.
Journal of Proteome Research
|
February 6, 2007
A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis
Guillermo Flores-Delgado, Cathy W Y Liu, Richard Sposto, et al.
Annals of Surgical Oncology
|
July 4, 2003
Breast cancer: do specialists make a difference?
Kristin A Skinner, James T Helsper, Dennis Deapen, et al.
Cancer Research
|
March 6, 2012
A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma
Ayaka M Silverman, Rie Nakata, Hiroyuki Shimada, et al.
Molecular Cancer Therapeutics
|
December 17, 2010
Combination of vorinostat and flavopiridol is selectively cytotoxic to multidrug-resistant neuroblastoma cell lines with mutant TP53
Jen-Ming Huang, Michael A Sheard, Lingyun Ji, et al.
Page
of 18
Search research articles
Search
Showing results (11-20 of 180) with videos related to
Sort By:
Page
of 18
Pediatric Hematology and Oncology
|
November 10, 2017
Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting
Alan S Wayne, Erika Shin-Kashiyama, Richard Sposto, et al.
Cancer
|
February 14, 2015
Improving access to novel agents for childhood leukemia
Weili Sun, Paul S Gaynon, Richard Sposto, et al.
Cancer Research
|
September 30, 2010
Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia
Tanja Andrea Gruber, Mi Sook Chang, Richard Sposto, et al.
Carcinogenesis
|
October 27, 2025
Recent evolution of risk analyses in atomic bomb survivor studies: new methods and applications
John Cologne, Munechika Misumi, Hanna Lindner, et al.
Leukemia
|
March 19, 2018
Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis
Maria Maruffi, Richard Sposto, Matthew J Oberley, et al.
Pediatric Blood & Cancer
|
January 22, 2013
A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors
Leo Mascarenhas, Marcio Malogolowkin, Saro H Armenian, et al.
Journal of Proteome Research
|
February 6, 2007
A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis
Guillermo Flores-Delgado, Cathy W Y Liu, Richard Sposto, et al.
Annals of Surgical Oncology
|
July 4, 2003
Breast cancer: do specialists make a difference?
Kristin A Skinner, James T Helsper, Dennis Deapen, et al.
Cancer Research
|
March 6, 2012
A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma
Ayaka M Silverman, Rie Nakata, Hiroyuki Shimada, et al.
Molecular Cancer Therapeutics
|
December 17, 2010
Combination of vorinostat and flavopiridol is selectively cytotoxic to multidrug-resistant neuroblastoma cell lines with mutant TP53
Jen-Ming Huang, Michael A Sheard, Lingyun Ji, et al.
Page
of 18